Wang et al. reported that SFI might reduce the expressions of TNF-α and IL-6 in rats with systemic inflammatory response syndrome (SIRS) via inhibiting the activity of NF-κB [10]. The gene discussed is NFKB1; the disease is systemic inflammatory response syndrome.